QAIALDO
LIVE

Serial Number

79417410

Owner

Nova Laboratories Ltd

Attorney

Molly B. Markley

Filing Date

Nov 21, 2024

Add to watchlist:

No watchlists yet
View on USPTO

QAIALDO Trademark

Serial Number: 79417410

QAIALDO is a trademark filed by Nova Laboratories Ltd on November 21, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Nova Laboratories Ltd (3 trademarks)

Martin House,

Entity Type: 99

Trademark Details

Filing Date

November 21, 2024

Registration Date

Not Registered

Published for Opposition

March 10, 2026

Goods & Services

Apparatus and devices for the delivery of pharmaceutical preparations, namely, droppers and syringes; apparatus and devices for the oral delivery of pharmaceutical preparations, namely, droppers and syringes; oral medical syringes

Pharmaceutical preparations, namely oral liquids for treating or alleviating the symptoms of heart failure, managing refractory oedema, or diagnosing and treating primary aldosteronism; pharmaceutical preparations, namely oral suspensions for treating or alleviating the symptoms of heart failure, managing refractory oedema, or diagnosing and treating primary aldosteronism; pharmaceutical preparations for the treatment of heart failure; pharmaceutical preparations for treating or alleviating the symptoms of heart failure; pharmaceutical preparations for use in the management of refractory oedema; pharmaceutical preparations for use in the management of refractory oedema associated with congestive heart failure, hepatic cirrhosis, malignant ascites, nephrotic syndrome or essential hypertension; pharmaceutical preparations for oral delivery for treating or alleviating the symptoms of heart failure, managing refractory oedema, or diagnosing and treating primary aldosteronism; pharmaceutical preparations containing spironolactone for oral delivery; oral liquids used for treating or alleviating the symptoms of heart failure, managing refractory oedema, and diagnosing and treating primary aldosteronism

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 17, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 16, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 16, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 16, 2026 TROA
REFUSAL PROCESSED BY IB
Aug 2, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 17, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jul 17, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 27, 2025 RFCR
NON-FINAL ACTION WRITTEN
May 26, 2025 CNRT
ASSIGNED TO EXAMINER
May 14, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 24, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 24, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 20, 2025 REPR